Retatrutide Syringe

Sizes: 1 mg, 2 mg, 4 mg and 8 mg.

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon pathways to deliver a comprehensive metabolic-support profile. This formulation is developed to assist with weight regulation, appetite control, and overall metabolic balance by influencing multiple hormonal signalling routes involved in energy use and glucose management.